Artificial intelligence is rapidly emerging across clinical trial operations, from patient identification to document automation and workflow optimization. However, many site organizations across the clinical trial ecosystem are still determining how to responsibly govern and operationalize AI, especially when it is in a tool provided by a sponsor or CRO. This session will share insights from a cross-industry collaboration that examined AI governance, operational readiness, and practical considerations for deploying AI at sites.